11
Participants
Start Date
March 31, 2005
Primary Completion Date
April 30, 2009
Study Completion Date
November 30, 2009
aspirin
81 mg flavored chewable tablets. Subjects between the ages of 2.0 and 4.99 years will receive half of an 81 mg aspirin tablet each day. Those older than 5.0 years will receive a daily 81 mg aspirin tablet. The subject will receive the study drug for a period of 12 months.
Collaborators (1)
University of Miami
OTHER
Bayer
INDUSTRY
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Rochester
OTHER